← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. HSIC
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

HSIC logoHenry Schein, Inc. (HSIC) P/E Ratio History

Historical price-to-earnings valuation from 1996 to 2025

Current P/E
22.2
Fair Value
5Y Avg P/E
21.6
+3% vs avg
PE Percentile
50%
Average
PEG Ratio
7.03
Expensive
TTM EPS$3.36
Price$72.44
5Y PE Range14.7 - 30.0
Earnings Yield4.51%

Loading P/E history...

HSIC Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
22.2vs21.6
+3%
In Line with History
vs. Healthcare
22.2vs22.1
+0%
In Line with Sector
vs. S&P 500
22.2vs25.2
-12%
Below Market
PEG Analysis
7.03
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 7% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 7, 2026, Henry Schein, Inc. (HSIC) trades at a price-to-earnings ratio of 22.2x, with a stock price of $72.44 and trailing twelve-month earnings per share of $3.36.

The current P/E is roughly in line with its 5-year average of 21.6x. Over the past five years, HSIC's P/E has ranged from a low of 14.7x to a high of 30.0x, placing the current valuation at the 50th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, HSIC is roughly in line with its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.

The PEG ratio of 7.03 (P/E divided by 7% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, HSIC trades roughly in line with the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HSIC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

HSIC P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
DXPE logoDXPEDXP Enterprises, Inc.
$3B33.9-+27%
MCK logoMCKMcKesson Corporation
$91B28.90.74+15%
CAH logoCAHCardinal Health, Inc.
$45B29.7-+87%
ALGN logoALGNAlign Technology, Inc.
$12B30.8-+1%
NVST logoNVSTEnvista Holdings Corp
$5B96.664.72+104%
GMED logoGMEDGlobus Medical, Inc.
$12B22.8Lowest0.73Best+423%Best
SYK logoSYKStryker Corporation
$112B34.82.34+8%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

HSIC Historical P/E Data (1996–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Sat Dec 27 2025 00:00:00 GM$76.13$3.2723.3x-79%
FY2025 Q3Sat Sep 27 2025 00:00:00 GM$66.06$3.1620.9x-81%
FY2025 Q2Sat Jun 28 2025 00:00:00 GM$73.27$3.1023.6x-79%
FY2025 Q1Sat Mar 29 2025 00:00:00 GM$68.62$3.2021.4x-81%
FY2024 Q4$69.20$3.0422.8x-79%
FY2024 Q3Sat Sep 28 2024 00:00:00 GM$73.22$2.4430.0x-73%
FY2024 Q2Sat Jun 29 2024 00:00:00 GM$64.10$2.7123.7x-79%
FY2024 Q1Sat Mar 30 2024 00:00:00 GM$75.52$2.9725.4x-77%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$75.71$3.1624.0x-78%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$74.25$3.3722.0x-80%
FY2023 Q2Sat Jul 01 2023 00:00:00 GM$81.10$3.4123.8x-78%
FY2023 Q1Sat Apr 01 2023 00:00:00 GM$81.54$3.5023.3x-79%

Average P/E for displayed period: 110.6x

See HSIC's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is HSIC Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare HSIC vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

HSIC — Frequently Asked Questions

Quick answers to the most common questions about buying HSIC stock.

Is HSIC stock overvalued or undervalued?

HSIC trades at 22.2x P/E, near its 5-year average of 21.6x. The 50th percentile ranking places valuation within normal historical bounds.

How does HSIC's valuation compare to peers?

Henry Schein, Inc. P/E of 22.2x compares to sector median of 22.1x. The premium reflects expected growth above peers.

What is HSIC's PEG ratio?

HSIC PEG ratio is 7.03. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1996-2025.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

HSIC P/E Ratio History (1996–2025)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.